Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The induction of trained immunity (TRIM) has emerged as an approach to fight against diseases. Several β-glucans and vaccines have been identified as trained immunity inductors, allowing heterologous protection for infectious diseases. Curiously, β-glucans from yeast, fungal, and plant species have been evaluated in clinical trials as vaccine adjuvants to combat infectious and non-communicable diseases. However, their adjuvant use for trained immunity-based vaccines (TIbV) remains scarcely studied. In this context, this review brings a scientific panorama of β-glucans and vaccines and offers perspectives on their combination to potentiate trained immunity induction and its benefits. In agreement with TRIM and TIbV concepts, we propose trained immunity-based adjuvanted vaccines (TIbAV) to refer to studies regarding this approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vaccine.2025.127240 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunomodulatory activity of Pleurotus pulmonarius crude extract to human monocyte against Cryptococcus neoformans.
BMC Complement Med Ther
July 2025
Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
Background: Treatment of Cryptococcus neoformans infection is still challenging due to high side effects and acquired drug resistance. Eliminating fungal infection requires monocytes and macrophages, which are weakened by the non-protective type-2 immune response induced by the pathogen. Pleurotus pulmonarius (PP) is an edible mushroom rich in bioactive molecules, particularly β-glucan.
View Article and Find Full Text PDFTrained Innate Immunity.
Adv Exp Med Biol
July 2025
Department of Veterinary Medicine (CAVM), United Arab Emirates University, Al Ain, UAE.
Recent research has increasingly highlighted the adaptive characteristics of the innate immune system, revealing its capacity for a heterologous memory of previous infections. Allergen-specific immunotherapy (AIT) has demonstrated that innate immune cells, such as monocytes, macrophages, and natural killer (NK) cells, can provide protection against specific diseases even in the absence of lymphocyte support. The mechanisms underlying innate host defense and the immunological memory of adaptive immunity differ significantly in terms of cellular populations and molecular pathways.
View Article and Find Full Text PDFTrained immunity-based Adjuvated vaccines (TIbAV) approach: β-glucans as example.
Vaccine
May 2025
Immunology & Vaccinology Group, Centro de Investigaciones Biológicas del Noroeste, S.C. Instituto Politécnico Nacional, 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S. C.P. 23096, Mexico. Electronic address:
The induction of trained immunity (TRIM) has emerged as an approach to fight against diseases. Several β-glucans and vaccines have been identified as trained immunity inductors, allowing heterologous protection for infectious diseases. Curiously, β-glucans from yeast, fungal, and plant species have been evaluated in clinical trials as vaccine adjuvants to combat infectious and non-communicable diseases.
View Article and Find Full Text PDFPlant-made trained immunity-based vaccines: Beyond one approach.
Int J Pharm
April 2025
Immunology & Vaccinology Group and Laboratorio Nacional CONAHCYT (SECIHTI) de Generación de Vacunas Veterinarias y Servicios de Diagnóstico (LNC-GVD). Centro de Investigaciones Biológicas del Noroeste, S.C. Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S. 23096, M
Plant-made vaccines and trained immunity-based vaccines (TIbV or TRAIMbV) represent two strategies for enhancing immunity against diseases. Plants provide an effective and cost-efficient vaccine production platform, while TIbV induces innate immune memory that can protect against both homologous and heterologous diseases. Both strategies are generally compatible; however, they have not been explored in a transdisciplinary manner.
View Article and Find Full Text PDFTrained immunity-based mucosal immunotherapies for the prevention of respiratory infections.
Trends Immunol
April 2025
The Innate Immune Response Group, La Paz University Hospital Research Institute (IdiPAZ), La Paz University Hospital, Madrid, Spain; Immunomodulation Laboratory, La Paz University Hospital Research Institute (IdiPAZ), La Paz University Hospital, Madrid, Spain. Electronic address: carlos.fresno@salud
The devastating impact of respiratory infections demonstrates the critical need for novel prophylactic vaccines. In this opinion article, we advocate for bacterial immunotherapies as a complementary tool in our fight against respiratory infections. These immunotherapies can activate a wide spectrum of immunological mechanisms, with trained immunity (TI) being particularly significant.
View Article and Find Full Text PDF